Over a Third of Stable Schizophrenia Patients Have Unrecognized Major Depression
A real-world cross-sectional study found that 36.1 percent of clinically stable chronic schizophrenia outpatients had an unrecognized major depressive episode ...
A real-world cross-sectional study found that 36.1 percent of clinically stable chronic schizophrenia outpatients had an unrecognized major depressive episode ...
A large United States claims study found that over one-third of individuals with schizophrenia developed metabolic disorders within six years ...
A narrative review examines the distinct metabolic, hormonal, and receptor pathways through which antipsychotics and mood stabilizers drive weight gain, ...
A study of 1,609 adults found that plasma metabolomics distinguished bipolar disorder, depression, and schizophrenia with over 88 percent accuracy ...
Researchers identified 60 CpG sites and seven differentially methylated regions in blood associated with serum antipsychotic drug concentrations in patients ...
A Delphi consensus panel of psychiatrists in Saudi Arabia recommends earlier adoption of long-acting injectable antipsychotics across schizophrenia stages to ...
A randomized controlled trial found that bifrontal transcranial direct current stimulation improved working memory in schizophrenia outpatients without evidence of ...
A multi-omics study combining brain molecular datasets prioritized candidate mitochondria-related genes associated with schizophrenia and cross-disorder psychiatric risk.
A Moroccan clinical study found that executive function impairments in schizophrenia correlated significantly with recognition deficits for dynamic, but not ...
A cross-sectional study reveals that caregiver distress tolerance is independently associated with schizophrenia patients' motivational medication adherence, while perfectionism selectively ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine